Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-25 @ 2:03 AM
NCT ID: NCT07194460
Eligibility Criteria: \# Eligibility Criteria * Inclusion Criteria: * Participants must be aged ≥60 years. * Diagnosis of schizophrenia based on the International Classification of Diseases - 10th Edition (ICD-10) or Diagnostic and Statistical Manual of Mental Disorders - 5th Edition (DSM-5). * Diagnosis must be made for ≥6 months, with clinical manifestations of schizophrenia (e.g., hallucinations, delusions, thought disorder, etc.). * No history of severe acute psychiatric episodes or hospitalizations within the last 3 months prior to enrollment. * Symptoms must be controllable, with no reliance on acute psychiatric intervention. * Participants must be able to understand the study's purpose and procedures and provide written informed consent. If the participant is unable to provide full informed consent (e.g., due to severe cognitive impairment), informed consent must be obtained from a legal guardian. * Exclusion Criteria: * Schizoaffective disorder or bipolar disorder with psychosis. * Elderly individuals with multiple chronic diseases but who still maintain good functional status and quality of life. * Presence of severe cardiovascular diseases, liver or kidney dysfunction, cerebrovascular diseases, or other physical conditions that may affect treatment. * Patients with contraindications to peripheral magnetic stimulation (PMS) treatment or EEG.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 60 Years
Maximum Age: 80 Years
Study: NCT07194460
Study Brief:
Protocol Section: NCT07194460